SGLT2 Inhibitors and Iron: More Than Meets the Eye

被引：0
作者：
Docherty, Kieran F. [1 ,2 ]
机构：
[1] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow, Scotland
[2] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Sch Cardiovasc & Metab Hlth, 126 Univ Pl, Glasgow G12 8TA, Scotland
来源：
JACC-HEART FAILURE | 2023年 / 11卷 / 11期
关键词：
heart failure; iron; SGLT2; inhibitors; HEART-FAILURE; MORTALITY;
D O I：
10.1016/j.jchf.2023.08.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1623 / 1625
页数：3
相关论文
共 18 条
[1]   Effects of empagliflozin on erythropoiesis in heart failure: data from the Empire HF trial [J].
Andersen, Camilla Fuchs ;
Omar, Massar ;
Glenthoj, Andreas ;
El Fassi, Daniel ;
Moller, Holger J. ;
Kurtzhals, Jorgen A. Lindholm ;
Styrishave, Bjarne ;
Kistorp, Caroline ;
Tuxen, Christian ;
Poulsen, Mikael K. ;
Faber, Jens ;
Kober, Lars ;
Gustafsson, Finn ;
Moller, Jacob E. ;
Schou, Morten ;
Jensen, Jesper .
EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (02) :226-234
[2]  
Angermann CE, 2021, CIRCULATION, V144, pe564
[3]   SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control [J].
Cowie, Martin R. ;
Fisher, Miles .
NATURE REVIEWS CARDIOLOGY, 2020, 17 (12) :761-772
[4]   Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF [J].
Docherty, Kieran F. ;
Welsh, Paul ;
Verma, Subodh ;
De Boer, Rudolf A. ;
O'Meara, Eileen ;
Bengtsson, Olof ;
Kober, Lars ;
Kosiborod, Mikhail N. ;
Hammarstedt, Ann ;
Langkilde, Anna Maria ;
Lindholm, Daniel ;
Little, Dustin J. ;
Sjostrand, Mikaela ;
Martinez, Felipe A. ;
Ponikowski, Piotr ;
Sabatine, Marc S. ;
Morrow, David A. ;
Schou, Morten ;
Solomon, Scott D. ;
Sattar, Naveed ;
Jhund, Pardeep S. ;
McMurray, John J., V .
CIRCULATION, 2022, 146 (13) :980-994
[5]   Effect of dapagliflozin on anaemia in DAPA-HF [J].
Docherty, Kieran F. ;
Curtain, James P. ;
Anand, Inder S. ;
Bengtsson, Olof ;
Inzucchi, Silvio E. ;
Kober, Lars ;
Kosiborod, Mikhail N. ;
Langkilde, Anna Maria ;
Martinez, Felipe A. ;
Ponikowski, Piotr ;
Sabatine, Marc S. ;
Schou, Morten ;
Sjostrand, Mikaela ;
Solomon, Scott D. ;
Jhund, Pardeep S. ;
McMurray, John J. V. .
EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (04) :617-628
[6]   Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced [J].
Ferreira, Joao Pedro ;
Anker, Stefan D. ;
Butler, Javed ;
Filippatos, Gerasimos ;
Iwata, Tomoko ;
Salsali, Afshin ;
Zeller, Cordula ;
Pocock, Stuart J. ;
Zannad, Faiez ;
Packer, Milton .
EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (04) :708-715
[7]   How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial [J].
Inzucchi, Silvio E. ;
Zinman, Bernard ;
Fitchett, David ;
Wanner, Christoph ;
Ferrannini, Ele ;
Schumacher, Martin ;
Schmoor, Claudia ;
Ohneberg, Kristin ;
Johansen, Odd Erik ;
George, Jyothis T. ;
Hantel, Stefan ;
Bluhmki, Erich ;
Lachin, John M. .
DIABETES CARE, 2018, 41 (02) :356-363
[8]   An essential cell-autonomous role for hepcidin in cardiac iron homeostasis [J].
Lakhal-Littleton, Samira ;
Wolna, Magda ;
Chung, Yu Jin ;
Christian, Helen C. ;
Heather, Lisa C. ;
Brescia, Marcella ;
Ball, Vicky ;
Diaz, Rebeca ;
Santos, Ana ;
Biggs, Daniel ;
Clarke, Kieran ;
Davies, Benjamin ;
Robbins, Peter A. .
ELIFE, 2016, 5
[9]   Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status [J].
Lorenzo, Miguel ;
Jacobs-Cacha, Conxita ;
Palau, Patricia ;
Amiguet, Martina ;
Seller, Julia ;
Nunez, Eduardo ;
Espriella, Rafael de la ;
Gorriz, Jose Luis ;
Minana, Gema ;
Sanchis, Juan ;
Bayes-Genis, Antoni ;
Soler, Maria Jose ;
Packer, Milton ;
Nunez, Julio .
JACC-HEART FAILURE, 2023, 11 (11) :1611-1622
[10]   The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy-the IRON-CRT trial [J].
Martens, Pieter ;
Dupont, Matthias ;
Dauw, Jeroen ;
Nijst, Petra ;
Herbots, Lieven ;
Dendale, Paul ;
Vandervoort, Pieter ;
Bruckers, Liesbeth ;
Tang, Wai Hong Wilson ;
Mullens, Wilfried .
EUROPEAN HEART JOURNAL, 2021, 42 (48) :4905-+
12